The American Association for Cancer Research (AACR) recently issued a policy statement that underscores the importance of safe, accurate, and effective diagnostic tests by recommending that the U.S. Food and Drug Administration (FDA) begin to actively exert its authority to regulate high-risk laboratory developed tests (LDTs) that are being utilized by physicians to make treatment decisions, including the tailoring of an individual’s cancer treatment regimen.

The Joint Commission has issued a new Sentinel Event Alert that addresses the risks of accidental medical tubing misconnections that can cause severe patient injury or death.